Global Acellular Dermal Matrix (ADM) Market Growth 2025-2031--LP INFORMATION, INC.

Global Acellular Dermal Matrix (ADM) Market Growth 2025-2031

Product Code: 1538643

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 116

Delivery Time: 2-3 business days

Global Acellular Dermal Matrix (ADM) Market Growth 2025-2031

Product Code: 1538643

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 116

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Acellular Dermal Matrix (ADM) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Acellular Dermal Matrix (ADM) is a biomaterial used in various surgical procedures, derived from human or animal skin tissue that has been processed to remove all cells, leaving behind a matrix of collagen and elastin fibers. This matrix serves as a scaffold to support tissue regeneration and healing by allowing the patient's own cells to populate and grow into the structure. ADM is commonly used in reconstructive surgeries, such as breast reconstruction, hernia repairs, and wound healing, because it provides structural support and promotes integration with the surrounding tissue. The acellular nature of the matrix reduces the risk of immune rejection and inflammatory responses, making it a versatile and effective tool in modern surgical practices.

United States market for Acellular Dermal Matrix (ADM) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Acellular Dermal Matrix (ADM) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Acellular Dermal Matrix (ADM) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Acellular Dermal Matrix (ADM) players cover AlloDerm (AbbVie), Zimmer Biomet, Stryker, DeCell Technologies, MatriDerm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Acellular Dermal Matrix (ADM) Industry Forecast” looks at past sales and reviews total world Acellular Dermal Matrix (ADM) sales in 2024, providing a comprehensive analysis by region and market sector of projected Acellular Dermal Matrix (ADM) sales for 2025 through 2031. With Acellular Dermal Matrix (ADM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acellular Dermal Matrix (ADM) industry.

This Insight Report provides a comprehensive analysis of the global Acellular Dermal Matrix (ADM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acellular Dermal Matrix (ADM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acellular Dermal Matrix (ADM) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acellular Dermal Matrix (ADM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acellular Dermal Matrix (ADM).

This report presents a comprehensive overview, market shares, and growth opportunities of Acellular Dermal Matrix (ADM) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Allogeneic ADM (Human Origin)

    Xenogeneic ADM (Animal Origin)

Segmentation by Application:

    Tissue Repair

    Plastic Surgery

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    AlloDerm (AbbVie)

    Zimmer Biomet

    Stryker

    DeCell Technologies

    MatriDerm

    MTF Biologics

    Smith+Nephew

    Medtronic

    RTI Surgical

    Straumann

    AlloSource

    Unitrump

    Lthink

Key Questions Addressed in this Report

What is the 10-year outlook for the global Acellular Dermal Matrix (ADM) market?

What factors are driving Acellular Dermal Matrix (ADM) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Acellular Dermal Matrix (ADM) market opportunities vary by end market size?

How does Acellular Dermal Matrix (ADM) break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Acellular Dermal Matrix (ADM) Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Acellular Dermal Matrix (ADM) by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Acellular Dermal Matrix (ADM) by Country/Region, 2020, 2024 & 2031
    2.2 Acellular Dermal Matrix (ADM) Segment by Type
        2.2.1 Allogeneic ADM (Human Origin)
        2.2.2 Xenogeneic ADM (Animal Origin)
    2.3 Acellular Dermal Matrix (ADM) Sales by Type
        2.3.1 Global Acellular Dermal Matrix (ADM) Sales Market Share by Type (2020-2025)
        2.3.2 Global Acellular Dermal Matrix (ADM) Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Acellular Dermal Matrix (ADM) Sale Price by Type (2020-2025)
    2.4 Acellular Dermal Matrix (ADM) Segment by Application
        2.4.1 Tissue Repair
        2.4.2 Plastic Surgery
        2.4.3 Others
    2.5 Acellular Dermal Matrix (ADM) Sales by Application
        2.5.1 Global Acellular Dermal Matrix (ADM) Sale Market Share by Application (2020-2025)
        2.5.2 Global Acellular Dermal Matrix (ADM) Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Acellular Dermal Matrix (ADM) Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Acellular Dermal Matrix (ADM) Breakdown Data by Company
        3.1.1 Global Acellular Dermal Matrix (ADM) Annual Sales by Company (2020-2025)
        3.1.2 Global Acellular Dermal Matrix (ADM) Sales Market Share by Company (2020-2025)
    3.2 Global Acellular Dermal Matrix (ADM) Annual Revenue by Company (2020-2025)
        3.2.1 Global Acellular Dermal Matrix (ADM) Revenue by Company (2020-2025)
        3.2.2 Global Acellular Dermal Matrix (ADM) Revenue Market Share by Company (2020-2025)
    3.3 Global Acellular Dermal Matrix (ADM) Sale Price by Company
    3.4 Key Manufacturers Acellular Dermal Matrix (ADM) Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Acellular Dermal Matrix (ADM) Product Location Distribution
        3.4.2 Players Acellular Dermal Matrix (ADM) Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Acellular Dermal Matrix (ADM) by Geographic Region
    4.1 World Historic Acellular Dermal Matrix (ADM) Market Size by Geographic Region (2020-2025)
        4.1.1 Global Acellular Dermal Matrix (ADM) Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Acellular Dermal Matrix (ADM) Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Acellular Dermal Matrix (ADM) Market Size by Country/Region (2020-2025)
        4.2.1 Global Acellular Dermal Matrix (ADM) Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Acellular Dermal Matrix (ADM) Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Acellular Dermal Matrix (ADM) Sales Growth
    4.4 APAC Acellular Dermal Matrix (ADM) Sales Growth
    4.5 Europe Acellular Dermal Matrix (ADM) Sales Growth
    4.6 Middle East & Africa Acellular Dermal Matrix (ADM) Sales Growth

5 Americas
    5.1 Americas Acellular Dermal Matrix (ADM) Sales by Country
        5.1.1 Americas Acellular Dermal Matrix (ADM) Sales by Country (2020-2025)
        5.1.2 Americas Acellular Dermal Matrix (ADM) Revenue by Country (2020-2025)
    5.2 Americas Acellular Dermal Matrix (ADM) Sales by Type (2020-2025)
    5.3 Americas Acellular Dermal Matrix (ADM) Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Acellular Dermal Matrix (ADM) Sales by Region
        6.1.1 APAC Acellular Dermal Matrix (ADM) Sales by Region (2020-2025)
        6.1.2 APAC Acellular Dermal Matrix (ADM) Revenue by Region (2020-2025)
    6.2 APAC Acellular Dermal Matrix (ADM) Sales by Type (2020-2025)
    6.3 APAC Acellular Dermal Matrix (ADM) Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Acellular Dermal Matrix (ADM) by Country
        7.1.1 Europe Acellular Dermal Matrix (ADM) Sales by Country (2020-2025)
        7.1.2 Europe Acellular Dermal Matrix (ADM) Revenue by Country (2020-2025)
    7.2 Europe Acellular Dermal Matrix (ADM) Sales by Type (2020-2025)
    7.3 Europe Acellular Dermal Matrix (ADM) Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Acellular Dermal Matrix (ADM) by Country
        8.1.1 Middle East & Africa Acellular Dermal Matrix (ADM) Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Acellular Dermal Matrix (ADM) Revenue by Country (2020-2025)
    8.2 Middle East & Africa Acellular Dermal Matrix (ADM) Sales by Type (2020-2025)
    8.3 Middle East & Africa Acellular Dermal Matrix (ADM) Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Acellular Dermal Matrix (ADM)
    10.3 Manufacturing Process Analysis of Acellular Dermal Matrix (ADM)
    10.4 Industry Chain Structure of Acellular Dermal Matrix (ADM)

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Acellular Dermal Matrix (ADM) Distributors
    11.3 Acellular Dermal Matrix (ADM) Customer

12 World Forecast Review for Acellular Dermal Matrix (ADM) by Geographic Region
    12.1 Global Acellular Dermal Matrix (ADM) Market Size Forecast by Region
        12.1.1 Global Acellular Dermal Matrix (ADM) Forecast by Region (2026-2031)
        12.1.2 Global Acellular Dermal Matrix (ADM) Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Acellular Dermal Matrix (ADM) Forecast by Type (2026-2031)
    12.7 Global Acellular Dermal Matrix (ADM) Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 AlloDerm (AbbVie)
        13.1.1 AlloDerm (AbbVie) Company Information
        13.1.2 AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.1.3 AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 AlloDerm (AbbVie) Main Business Overview
        13.1.5 AlloDerm (AbbVie) Latest Developments
    13.2 Zimmer Biomet
        13.2.1 Zimmer Biomet Company Information
        13.2.2 Zimmer Biomet Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.2.3 Zimmer Biomet Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Zimmer Biomet Main Business Overview
        13.2.5 Zimmer Biomet Latest Developments
    13.3 Stryker
        13.3.1 Stryker Company Information
        13.3.2 Stryker Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.3.3 Stryker Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Stryker Main Business Overview
        13.3.5 Stryker Latest Developments
    13.4 DeCell Technologies
        13.4.1 DeCell Technologies Company Information
        13.4.2 DeCell Technologies Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.4.3 DeCell Technologies Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 DeCell Technologies Main Business Overview
        13.4.5 DeCell Technologies Latest Developments
    13.5 MatriDerm
        13.5.1 MatriDerm Company Information
        13.5.2 MatriDerm Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.5.3 MatriDerm Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 MatriDerm Main Business Overview
        13.5.5 MatriDerm Latest Developments
    13.6 MTF Biologics
        13.6.1 MTF Biologics Company Information
        13.6.2 MTF Biologics Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.6.3 MTF Biologics Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 MTF Biologics Main Business Overview
        13.6.5 MTF Biologics Latest Developments
    13.7 Smith+Nephew
        13.7.1 Smith+Nephew Company Information
        13.7.2 Smith+Nephew Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.7.3 Smith+Nephew Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Smith+Nephew Main Business Overview
        13.7.5 Smith+Nephew Latest Developments
    13.8 Medtronic
        13.8.1 Medtronic Company Information
        13.8.2 Medtronic Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.8.3 Medtronic Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Medtronic Main Business Overview
        13.8.5 Medtronic Latest Developments
    13.9 RTI Surgical
        13.9.1 RTI Surgical Company Information
        13.9.2 RTI Surgical Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.9.3 RTI Surgical Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 RTI Surgical Main Business Overview
        13.9.5 RTI Surgical Latest Developments
    13.10 Straumann
        13.10.1 Straumann Company Information
        13.10.2 Straumann Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.10.3 Straumann Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Straumann Main Business Overview
        13.10.5 Straumann Latest Developments
    13.11 AlloSource
        13.11.1 AlloSource Company Information
        13.11.2 AlloSource Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.11.3 AlloSource Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 AlloSource Main Business Overview
        13.11.5 AlloSource Latest Developments
    13.12 Unitrump
        13.12.1 Unitrump Company Information
        13.12.2 Unitrump Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.12.3 Unitrump Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 Unitrump Main Business Overview
        13.12.5 Unitrump Latest Developments
    13.13 Lthink
        13.13.1 Lthink Company Information
        13.13.2 Lthink Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
        13.13.3 Lthink Acellular Dermal Matrix (ADM) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 Lthink Main Business Overview
        13.13.5 Lthink Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Acellular Dermal Matrix (ADM) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Acellular Dermal Matrix (ADM) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Allogeneic ADM (Human Origin)
 Table 4. Major Players of Xenogeneic ADM (Animal Origin)
 Table 5. Global Acellular Dermal Matrix (ADM) Sales by Type (2020-2025) & (K Units)
 Table 6. Global Acellular Dermal Matrix (ADM) Sales Market Share by Type (2020-2025)
 Table 7. Global Acellular Dermal Matrix (ADM) Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2020-2025)
 Table 9. Global Acellular Dermal Matrix (ADM) Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Acellular Dermal Matrix (ADM) Sale by Application (2020-2025) & (K Units)
 Table 11. Global Acellular Dermal Matrix (ADM) Sale Market Share by Application (2020-2025)
 Table 12. Global Acellular Dermal Matrix (ADM) Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2020-2025)
 Table 14. Global Acellular Dermal Matrix (ADM) Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Acellular Dermal Matrix (ADM) Sales by Company (2020-2025) & (K Units)
 Table 16. Global Acellular Dermal Matrix (ADM) Sales Market Share by Company (2020-2025)
 Table 17. Global Acellular Dermal Matrix (ADM) Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Company (2020-2025)
 Table 19. Global Acellular Dermal Matrix (ADM) Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Acellular Dermal Matrix (ADM) Producing Area Distribution and Sales Area
 Table 21. Players Acellular Dermal Matrix (ADM) Products Offered
 Table 22. Acellular Dermal Matrix (ADM) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Acellular Dermal Matrix (ADM) Sales by Geographic Region (2020-2025) & (K Units)
 Table 26. Global Acellular Dermal Matrix (ADM) Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Acellular Dermal Matrix (ADM) Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Acellular Dermal Matrix (ADM) Sales by Country/Region (2020-2025) & (K Units)
 Table 30. Global Acellular Dermal Matrix (ADM) Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Acellular Dermal Matrix (ADM) Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Acellular Dermal Matrix (ADM) Sales by Country (2020-2025) & (K Units)
 Table 34. Americas Acellular Dermal Matrix (ADM) Sales Market Share by Country (2020-2025)
 Table 35. Americas Acellular Dermal Matrix (ADM) Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Acellular Dermal Matrix (ADM) Sales by Type (2020-2025) & (K Units)
 Table 37. Americas Acellular Dermal Matrix (ADM) Sales by Application (2020-2025) & (K Units)
 Table 38. APAC Acellular Dermal Matrix (ADM) Sales by Region (2020-2025) & (K Units)
 Table 39. APAC Acellular Dermal Matrix (ADM) Sales Market Share by Region (2020-2025)
 Table 40. APAC Acellular Dermal Matrix (ADM) Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Acellular Dermal Matrix (ADM) Sales by Type (2020-2025) & (K Units)
 Table 42. APAC Acellular Dermal Matrix (ADM) Sales by Application (2020-2025) & (K Units)
 Table 43. Europe Acellular Dermal Matrix (ADM) Sales by Country (2020-2025) & (K Units)
 Table 44. Europe Acellular Dermal Matrix (ADM) Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Acellular Dermal Matrix (ADM) Sales by Type (2020-2025) & (K Units)
 Table 46. Europe Acellular Dermal Matrix (ADM) Sales by Application (2020-2025) & (K Units)
 Table 47. Middle East & Africa Acellular Dermal Matrix (ADM) Sales by Country (2020-2025) & (K Units)
 Table 48. Middle East & Africa Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Acellular Dermal Matrix (ADM) Sales by Type (2020-2025) & (K Units)
 Table 50. Middle East & Africa Acellular Dermal Matrix (ADM) Sales by Application (2020-2025) & (K Units)
 Table 51. Key Market Drivers & Growth Opportunities of Acellular Dermal Matrix (ADM)
 Table 52. Key Market Challenges & Risks of Acellular Dermal Matrix (ADM)
 Table 53. Key Industry Trends of Acellular Dermal Matrix (ADM)
 Table 54. Acellular Dermal Matrix (ADM) Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Acellular Dermal Matrix (ADM) Distributors List
 Table 57. Acellular Dermal Matrix (ADM) Customer List
 Table 58. Global Acellular Dermal Matrix (ADM) Sales Forecast by Region (2026-2031) & (K Units)
 Table 59. Global Acellular Dermal Matrix (ADM) Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Acellular Dermal Matrix (ADM) Sales Forecast by Country (2026-2031) & (K Units)
 Table 61. Americas Acellular Dermal Matrix (ADM) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Acellular Dermal Matrix (ADM) Sales Forecast by Region (2026-2031) & (K Units)
 Table 63. APAC Acellular Dermal Matrix (ADM) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Acellular Dermal Matrix (ADM) Sales Forecast by Country (2026-2031) & (K Units)
 Table 65. Europe Acellular Dermal Matrix (ADM) Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Acellular Dermal Matrix (ADM) Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Middle East & Africa Acellular Dermal Matrix (ADM) Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Acellular Dermal Matrix (ADM) Sales Forecast by Type (2026-2031) & (K Units)
 Table 69. Global Acellular Dermal Matrix (ADM) Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Acellular Dermal Matrix (ADM) Sales Forecast by Application (2026-2031) & (K Units)
 Table 71. Global Acellular Dermal Matrix (ADM) Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. AlloDerm (AbbVie) Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 73. AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 74. AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. AlloDerm (AbbVie) Main Business
 Table 76. AlloDerm (AbbVie) Latest Developments
 Table 77. Zimmer Biomet Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 78. Zimmer Biomet Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 79. Zimmer Biomet Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Zimmer Biomet Main Business
 Table 81. Zimmer Biomet Latest Developments
 Table 82. Stryker Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 83. Stryker Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 84. Stryker Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Stryker Main Business
 Table 86. Stryker Latest Developments
 Table 87. DeCell Technologies Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 88. DeCell Technologies Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 89. DeCell Technologies Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. DeCell Technologies Main Business
 Table 91. DeCell Technologies Latest Developments
 Table 92. MatriDerm Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 93. MatriDerm Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 94. MatriDerm Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. MatriDerm Main Business
 Table 96. MatriDerm Latest Developments
 Table 97. MTF Biologics Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 98. MTF Biologics Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 99. MTF Biologics Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. MTF Biologics Main Business
 Table 101. MTF Biologics Latest Developments
 Table 102. Smith+Nephew Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 103. Smith+Nephew Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 104. Smith+Nephew Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Smith+Nephew Main Business
 Table 106. Smith+Nephew Latest Developments
 Table 107. Medtronic Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 108. Medtronic Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 109. Medtronic Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Medtronic Main Business
 Table 111. Medtronic Latest Developments
 Table 112. RTI Surgical Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 113. RTI Surgical Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 114. RTI Surgical Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. RTI Surgical Main Business
 Table 116. RTI Surgical Latest Developments
 Table 117. Straumann Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 118. Straumann Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 119. Straumann Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Straumann Main Business
 Table 121. Straumann Latest Developments
 Table 122. AlloSource Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 123. AlloSource Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 124. AlloSource Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. AlloSource Main Business
 Table 126. AlloSource Latest Developments
 Table 127. Unitrump Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 128. Unitrump Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 129. Unitrump Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. Unitrump Main Business
 Table 131. Unitrump Latest Developments
 Table 132. Lthink Basic Information, Acellular Dermal Matrix (ADM) Manufacturing Base, Sales Area and Its Competitors
 Table 133. Lthink Acellular Dermal Matrix (ADM) Product Portfolios and Specifications
 Table 134. Lthink Acellular Dermal Matrix (ADM) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 135. Lthink Main Business
 Table 136. Lthink Latest Developments


List of Figures
 Figure 1. Picture of Acellular Dermal Matrix (ADM)
 Figure 2. Acellular Dermal Matrix (ADM) Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Acellular Dermal Matrix (ADM) Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Acellular Dermal Matrix (ADM) Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Acellular Dermal Matrix (ADM) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Acellular Dermal Matrix (ADM) Sales Market Share by Country/Region (2024)
 Figure 10. Acellular Dermal Matrix (ADM) Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Allogeneic ADM (Human Origin)
 Figure 12. Product Picture of Xenogeneic ADM (Animal Origin)
 Figure 13. Global Acellular Dermal Matrix (ADM) Sales Market Share by Type in 2025
 Figure 14. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2020-2025)
 Figure 15. Acellular Dermal Matrix (ADM) Consumed in Tissue Repair
 Figure 16. Global Acellular Dermal Matrix (ADM) Market: Tissue Repair (2020-2025) & (K Units)
 Figure 17. Acellular Dermal Matrix (ADM) Consumed in Plastic Surgery
 Figure 18. Global Acellular Dermal Matrix (ADM) Market: Plastic Surgery (2020-2025) & (K Units)
 Figure 19. Acellular Dermal Matrix (ADM) Consumed in Others
 Figure 20. Global Acellular Dermal Matrix (ADM) Market: Others (2020-2025) & (K Units)
 Figure 21. Global Acellular Dermal Matrix (ADM) Sale Market Share by Application (2024)
 Figure 22. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Application in 2025
 Figure 23. Acellular Dermal Matrix (ADM) Sales by Company in 2025 (K Units)
 Figure 24. Global Acellular Dermal Matrix (ADM) Sales Market Share by Company in 2025
 Figure 25. Acellular Dermal Matrix (ADM) Revenue by Company in 2025 ($ millions)
 Figure 26. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Company in 2025
 Figure 27. Global Acellular Dermal Matrix (ADM) Sales Market Share by Geographic Region (2020-2025)
 Figure 28. Global Acellular Dermal Matrix (ADM) Revenue Market Share by Geographic Region in 2025
 Figure 29. Americas Acellular Dermal Matrix (ADM) Sales 2020-2025 (K Units)
 Figure 30. Americas Acellular Dermal Matrix (ADM) Revenue 2020-2025 ($ millions)
 Figure 31. APAC Acellular Dermal Matrix (ADM) Sales 2020-2025 (K Units)
 Figure 32. APAC Acellular Dermal Matrix (ADM) Revenue 2020-2025 ($ millions)
 Figure 33. Europe Acellular Dermal Matrix (ADM) Sales 2020-2025 (K Units)
 Figure 34. Europe Acellular Dermal Matrix (ADM) Revenue 2020-2025 ($ millions)
 Figure 35. Middle East & Africa Acellular Dermal Matrix (ADM) Sales 2020-2025 (K Units)
 Figure 36. Middle East & Africa Acellular Dermal Matrix (ADM) Revenue 2020-2025 ($ millions)
 Figure 37. Americas Acellular Dermal Matrix (ADM) Sales Market Share by Country in 2025
 Figure 38. Americas Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2020-2025)
 Figure 39. Americas Acellular Dermal Matrix (ADM) Sales Market Share by Type (2020-2025)
 Figure 40. Americas Acellular Dermal Matrix (ADM) Sales Market Share by Application (2020-2025)
 Figure 41. United States Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 42. Canada Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 43. Mexico Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 44. Brazil Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 45. APAC Acellular Dermal Matrix (ADM) Sales Market Share by Region in 2025
 Figure 46. APAC Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2020-2025)
 Figure 47. APAC Acellular Dermal Matrix (ADM) Sales Market Share by Type (2020-2025)
 Figure 48. APAC Acellular Dermal Matrix (ADM) Sales Market Share by Application (2020-2025)
 Figure 49. China Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 50. Japan Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 51. South Korea Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 52. Southeast Asia Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 53. India Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 54. Australia Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 55. China Taiwan Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 56. Europe Acellular Dermal Matrix (ADM) Sales Market Share by Country in 2025
 Figure 57. Europe Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2020-2025)
 Figure 58. Europe Acellular Dermal Matrix (ADM) Sales Market Share by Type (2020-2025)
 Figure 59. Europe Acellular Dermal Matrix (ADM) Sales Market Share by Application (2020-2025)
 Figure 60. Germany Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 61. France Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 62. UK Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 63. Italy Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 64. Russia Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 65. Middle East & Africa Acellular Dermal Matrix (ADM) Sales Market Share by Country (2020-2025)
 Figure 66. Middle East & Africa Acellular Dermal Matrix (ADM) Sales Market Share by Type (2020-2025)
 Figure 67. Middle East & Africa Acellular Dermal Matrix (ADM) Sales Market Share by Application (2020-2025)
 Figure 68. Egypt Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 69. South Africa Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 70. Israel Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 71. Turkey Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 72. GCC Countries Acellular Dermal Matrix (ADM) Revenue Growth 2020-2025 ($ millions)
 Figure 73. Manufacturing Cost Structure Analysis of Acellular Dermal Matrix (ADM) in 2025
 Figure 74. Manufacturing Process Analysis of Acellular Dermal Matrix (ADM)
 Figure 75. Industry Chain Structure of Acellular Dermal Matrix (ADM)
 Figure 76. Channels of Distribution
 Figure 77. Global Acellular Dermal Matrix (ADM) Sales Market Forecast by Region (2026-2031)
 Figure 78. Global Acellular Dermal Matrix (ADM) Revenue Market Share Forecast by Region (2026-2031)
 Figure 79. Global Acellular Dermal Matrix (ADM) Sales Market Share Forecast by Type (2026-2031)
 Figure 80. Global Acellular Dermal Matrix (ADM) Revenue Market Share Forecast by Type (2026-2031)
 Figure 81. Global Acellular Dermal Matrix (ADM) Sales Market Share Forecast by Application (2026-2031)
 Figure 82. Global Acellular Dermal Matrix (ADM) Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

AlloDerm (AbbVie)

Zimmer Biomet

Stryker

DeCell Technologies

MatriDerm

MTF Biologics

Smith+Nephew

Medtronic

RTI Surgical

Straumann

AlloSource

Unitrump

Lthink

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff